- Parathyroid disease is a group of conditions encompassing abnormalities in the function or structure of the parathyroid glands located in the neck.
- Parathyroid hormone (PTH) levels may become excessive or insufficient, and causes may include benign tumors, gland enlargement, surgery or injury, and endocrine or genetic diseases.
- Since PTH regulates the balance of calcium and phosphorus in the blood, secretion abnormalities can disrupt this balance.
- Typical symptoms may include fatigue, muscle weakness, thirst and frequent urination, numbness, muscle cramps, bone pain, or kidney stones associated with hypercalcemia or hypocalcemia.
- Symptoms and risks may vary depending on the cause, degree of hormonal abnormality, kidney function, vitamin D status, medications taken, comorbidities, and genetic background.
- Mild abnormalities may be asymptomatic, but persistent or severe hormone/electrolyte abnormalities can lead to bone weakening, kidney stones, decreased kidney function, or neuromuscular symptoms.
- Diagnosis is performed by evaluating calcium, phosphorus, and PTH in the blood and kidney function, and if necessary, conducting vitamin D tests, urinalysis, ultrasound, or other imaging tests together.
- Calcium and PTH results must be interpreted together, and their significance may vary depending on kidney function, vitamin D status, medications taken, timing of the test, and laboratory reference ranges.
- The basic goal of management is to restore the balance of calcium and phosphorus and to control the causes related to parathyroid dysfunction.
- Treatment is not uniformly determined; the decision regarding observation, drug therapy, or surgery is made by comprehensively considering the cause, symptoms, test results, and risk of complications.